Natco Pharma shares dip over 2% after Rs 2,000-crore stake buy in South Africa’s Adcock Ingram
Natco Pharma shares slipped 2.5% to Rs 1,009 apiece on the BSE in Thursday’s trade after the company announced its plan to acquire a 35.75% stake in South Africa-based Adcock…
Natco Pharma appoints Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda
Telangana: Natco Pharma has appointed Yarramshetty Krishna Rao as Senior Vice President – Operations at Mekaguda of the Company. Yarramshetty Krishna Rao has overall 33 years of experience in the…
Natco API plant gets one observation from FDA
Hyderabad: Drugmaker, Natco Pharma, Mekaguda-based Active Pharmaceutical Ingredients (API) plant has received one observation under the form 483 from the US Food and Drug Administration (FDA). In a stock exchange…
Natco Pharma mulling acquisition in RoW market to strengthen base business
Natco Pharma is mulling acquisitions in the Rest of the World (RoW) markets to strengthen its base business. “The acquisition space is to strengthen our base business. We have the…
BackBack Natco Pharma share price rises 8% to 52 week high post Q4 results
Stock Market Today: Nacto Pharma share price gained almost 8% in the morning trade post Q4 results that were declared by the company post market hours on Monday. The Natco…
Anti-trust lawsuit against Natco Pharma over generic cancer drug dismissed in US
Natco Pharma on December 21 said anti-trust claims against it regarding a generic cancer treatment drug in the US have been dismissed. In September this year, the company had stated…